The US. diabetic foot ulcer treatment market size is calculated at USD 1.68 billion in 2025 and is predicted to attain around USD 2.92 billion by 2035, expanding at a CAGR of 5.7% from 2026 to 2035. The market is highly driven by factors such as the rising prevalence of diabetic patients in the region, the growing geriatric population, and higher demand for advanced wound care treatment options.

U.S. Diabetic Foot Ulcer Treatment Market Statical Scope

The U.S. Diabetic foot ulcer treatment market is majorly expanding due to the availability of advanced wound care dressings in options of foam and hydrocolloid, along with advanced biologics and skin grafts. Improved tissue regeneration for chronic conditions is also a major market driver. Rising healthcare expenditure and higher demand for advanced treatment options also help to propel the market's growth. The presence of major market players in the region also helps to fuel the market's growth.

U.S. Diabetic Foot Ulcer Treatment Market Share, By Treatment, 2025, (%)

• Wound Care Dressings- The segment has a dominant share of 42% in the market in 2025, as it signifies healing and protection of the ulcer from any form of infection or moisture.
• Biologics- The segment holds 30% of the market share and offers advanced regenerative treatment options, such as growth factors for quicker healing.
• Therapy Devices- The segment accounts for 15% of the market share with options such as negative pressure wound therapy and electrical stimulation devices.

U.S. Diabetic Foot Ulcer Treatment Market Share, By Ulcer Type, 2025, (%)

• Neuro-ischemic Ulcers- The segment has a dominant share of 45% of the market in 2025, as it reflects a combination of neuropathic and ischemic ulcers, leading to a more intensive treatment solution.
• Neuropathic Ulcers- The segment holds 35% of the market share as it is one of the most common forms of neuropathic ulcers found in diabetic patients.
• Ischemic Ulcers- The segment holds 20% of the market share, as such issues are commonly found in diabetic patients with poor blood circulation.

U.S. Diabetic Foot Ulcer Treatment Market Share, By End Use, 2025, (%)

• Hospitals- The segment accounts for 55% of the market share, as it highlights the comprehensive care provided by hospitals to diabetic patients with foot ulcers for quicker healing.
• Ambulatory Imaging Center- The segment holds 20% of the market share as it provides diagnostic imaging services for easy ulcer assessment.
• Homecare- The segment has 25% of the market share and is highly preferred by the aged patients for enhanced comfort, along with efficient results

Top Companies in the U.S. Diabetic Foot Ulcer Treatment Market

• ConvaTec, Group Plc
• Acelity L.P., Inc.
• 3M Health Care
• Coloplast Corp.
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, LP.
• Molnlycke Health Care AB
• Medtronic Plc

Segments Covered in the Report

By Treatment

• Wound Care Dressings
• Biologics
• Therapy Devices
• Antibiotic Medications
• Others

By Ulcer Type

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuro-ischemic Ulcers

By End Use

• Hospitals
• Ambulatory Imaging Centers
• Home Care